A scattering of S&P 500 companies has yet to report third quarter results, with most of the reports, including from Nvidia ...

On Thursday, Eli Lilly and Co. (NYSE:LLY) released data from a Phase 2 trial evaluating the safety and efficacy of eloralintide, an investigational once-weekly, selective amylin receptor agonist, in ...

(Reuters) — Indianapolis-based Lilly said on Wednesday it is partnering with Walmart to expand access to Lilly’s weight-loss drug Zepbound, which will be offered for pick-up at Walmart pharmacies ...

Editor's note: The below contains spoilers for IT: Welcome to Derry Episode 1. Stephen King has been writing about nightmarish creatures for over half a century, but his greatest might be Pennywise ...

With the greater part of third quarter earnings results in the rearview mirror, investors are looking closely at marquee ...

"I got really, really thin when I was feeling at my lowest, in the past year or so," the singer said Catherine Santino is a Style Writer-Reporter at PEOPLE. She began as a contributor for PEOPLE in ...

Lily Allen told Perfect that she got a boob job to help with her body proportion after changes to her weight and body size "I got really, really thin when I was feeling at my lowest, in the past year ...

Eli Lilly's shares have increased by about 10% over the past month. Clinical progress in the past few weeks has helped solidify its lead in the weight loss market. The company's prospects remain ...

Lilly Singh, who hosted the NBC’s late night talk series “A Little Late with Lilly Singh,” opened up about the downfall of her show, saying that she believes the production wasn’t set up to succeed.

There's a chance that an investigational obesity drug late in its development stage could be fast-tracked for FDA approval. This would be under a new program launched by the regulator. A news article ...